Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia [Phase 3]
Phase 3 extension study of pimavanserin as adjunctive treatment for schizophrenia was terminated; results from the study were posted on 2025…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008) [Phase 2]
Phase 2 trial MK-8189-008 evaluates the efficacy and safety of MK-8189 in participants with an acute episode of schizophrenia. Results have …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ERG Components in Schizophrenia and Bipolar Disorder Type I
DiaMentis' clinical trial researching ERG components in schizophrenia and Bipolar I disorder is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: EPI-MINN: Targeting Cognition and Motivation - National [NA]
An update on the EPI-MINN trial from the University of Minnesota evaluating cognition and motivation in several psychotic disorders; the stu…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia
UT Southwestern's clinical trial examines how aging influences the course and neurobiology of schizophrenia, using imaging and biomarker app…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder [NA]
A cost-utility study evaluating cognitive-behavioral therapy for managing auditory hallucinations in schizophrenia, currently not recruiting…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: A Remote Life Balance Training Program for People With Schizophrenia [NA]
Clinical trial update announcing enrollment for a remote life balance training program for people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index [NA]
A completed clinical trial evaluating whether physical exercise alters simple inflammatory markers and systemic immune indices in people wit…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: MBRS-Based Psychoeducation in Patients With Schizophrenia [NA]
This completed clinical trial evaluated MBRS-based psychoeducation for patients with schizophrenia, focusing on mindfulness-based strategies…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Tele-group Cognitive Behavioural Family Intervention for Individuals With Schizophrenia and Their Families [NA]
A clinical trial update describes a tele-group cognitive behavioural family intervention for individuals with schizophrenia and their famili…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders [NA]
A terminated clinical trial sponsored by University Hospital, Strasbourg, studying time, self, and spontaneous mental activities in patients…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Emotion and Motivation in Patients With Psychosis [NA]
This clinical trial update indicates that study NCT02853019, examining emotion and motivation in people with schizophrenia, has been termina…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Outcomes From Remediation and Behavioural Intervention Techniques [NA]
An update on a trial evaluating remediation and behavioural intervention techniques for schizophrenia and related psychotic disorders, curre…
-
FDA approval · 2025-08-18FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for haloperidol decanoate from Mylan Institutional LLC, a long-acting injectable antipsychotic.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents [NA]
A clinical trial from Shanghai Mental Health Center is investigating prediction and intervention effects of rehabilitation status for severe…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Approaches For ThE pRioritization of Patients in priMAry Care Post-COVID To Reduce Health Inequities (AFTERMATH) [NA]
A not-yet-recruiting clinical trial registered on ClinicalTrials.gov, led by Unity Health Toronto. It investigates prioritization of patient…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Recovery in Telling Life Stories [NA]
This ClinicalTrials.gov entry indicates a University of Aarhus-led study titled 'Recovery in Telling Life Stories' that is currently recruit…
-
FDA approval · 2025-08-12FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Lurasidone hydrochloride submitted by Sun Pharmaceutical Industries, Inc. The action relates…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use. [NA]
This completed study evaluated the CHAMPION-ECHO educational program to improve clozapine use in schizophrenia and schizoaffective disorder.…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Adjunctive iTBS for First-Episode Schizophrenia [NA]
The clinical trial evaluating adjunctive intermittent theta-burst stimulation for first-episode schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Individualizing Incentives for Alcohol in the Severely Mentally Ill [NA]
This clinical trial update reports the completion of a study evaluating individualized incentives to address alcohol use in severely mentall…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum Disorders
This clinical trial update describes a study examining Obsessive-Compulsive Disorder in relation to insight, trauma, and links to schizophre…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: The Effect of Virtual Reality on Cognitive Skills in Schizophrenia [NA]
A completed clinical trial evaluating the effect of virtual reality-based cognitive training on cognitive abilities in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Brain Stimulation And Group Therapy to Improve Gesture and Social Skills in Psychosis (BrAGG-SoS) [NA]
A completed clinical trial evaluating brain stimulation combined with group therapy to improve gesture and social skills in individuals with…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Value of Voxel-Based Morphometry in Schizophrenia
This clinical trial, sponsored by Assiut University, is evaluating voxel-based morphometry as a biomarker in schizophrenia. Recruitment has …